Updated molecular analyses of exons 19 and 21 of the epidermal growth factor receptor (EGFR) gene and codons 12 and 13 of the KRAS gene in non-small cell lung cancer (NSCLC) patients treated with erlotinib in National Cancer Institute of Cancer

被引：0
|
作者：
Shepherd, F. A.
Ding, K.
Sakurada, A.
Santos, G. Da Cunha
Zhu, C.
Seymour, L.
Whitehead, M.
Kamel-Reid, S.
Squire, J.
Tsao, M. S.
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] Natl Canc Inst Canada, Kingston, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7571
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib
    Heigener, David F.
    Reck, Martin
    ADVANCES IN THERAPY, 2011, 28 (02) : 126 - 133
  • [22] Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib
    David F. Heigener
    Martin Reck
    Advances in Therapy, 2011, 28 : 126 - 133
  • [23] Effect of epidermal growth factor receptor gene mutation on bevacizumab combined with erlotinib in the treatment of non-small cell lung cancer
    Yuan, Gao
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 5175 - 5178
  • [24] Changes in Circulating Epidermal Growth Factor Receptor (EGFR) during Radiotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients
    Ye, Ping
    Zhao, Jing
    Maihle, Nita
    Wang, Shulian
    Jin, Jianyue
    Kong, Feng-Ming
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S605 - S605
  • [25] MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)
    Nuzzo, C.
    Sperduti, I.
    Marchetti, A.
    Cianciulli, A. M.
    Mottolese, M.
    Buttitta, F.
    Visca, P.
    Cecere, F. L.
    Cognetti, F.
    Milella, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 105 - 105
  • [26] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Previously documented mutations in the epidermal growth factor receptor (EGFR) gene in a non-small cell lung cancer (NSCLC) population treated with gefitinib are not associated with response.
    Bebb, D. G.
    Pugh, T.
    Sutcliffe, M.
    Barclay, L.
    Fee, J.
    O'Connor, R.
    Vielkind, J.
    Murray, N.
    Laskin, J. J.
    Marra, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 404S - 404S
  • [28] Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer
    Tomizawa, Y
    Iijima, H
    Sunaga, N
    Sato, K
    Takise, A
    Otani, Y
    Tanaka, S
    Suga, T
    Saito, R
    Ishizuka, T
    Dobashi, K
    Minna, JD
    Nakajima, T
    Mori, M
    CLINICAL CANCER RESEARCH, 2005, 11 (19) : 6816 - 6822
  • [29] Prevalence of mutation in the epidermal growth factor receptor gene in Chinese patients with non-small cell lung cancer
    Jiang, B.
    Zhu, Z. -Z.
    Liu, F.
    Hou, L. -F.
    Gu, J.
    Chen, E.
    Tzeng, C. -M.
    Zhu, G.
    CLINICAL ONCOLOGY, 2006, 18 (08) : 635 - 635
  • [30] Comparison between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in the corresponding recurrent tumor of the lung
    Zhang Peng
    Jiang Gening
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S934 - S934
12345